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Abstract 
Antioxidants may be beneficial for the treatment of certain neurological diseases since 
oxidative stress and inflammation are believed to contribute to neurological degenerative 
disorders. We performed an analysis of the biochemical attributes and neurobiological 
activity of extracts found in Vaccinium species. Wild blueberries, native to Newfoundland 
and Labrador (NL), were collected from different locations. Biochemical assays were 
performed to determine the phenolic content of extracts and antioxidant capacity. To 
quantify and identify major anthocyanins in extracts, High-Performance Liquid 
Chromatography Mass-Spectroscopy analysis was performed. Microglial cells isolated 
from mouse brains were treated with glutamate or α-synuclein to induce inflammatory 
responses, and treatment with extracts was conducted to assess neuroprotective effects. 
Results showed that wild blueberry fruits and leaves native to NL are high sources of 
antioxidants. Leaves have an overall significantly higher level of antioxidants compared 
to the fruits. Utilizing HPLC-MS, more anthocyanins were identified in blueberry fruit 
than leaves, but the anthocyanins in leaf extracts were present in higher quantity. Cell 
culture experiments demonstrated the preventative role blueberry fruits and leaves had on 
activated microglial cells mimicking conditions in the neurodegenerative conditions. 
Overall, findings showed that that both fruit and leaf extracts significantly reduced the 
inflammatory response of brain cells seen in certain neurodegenerative disease.   
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Chapter 1: Introduction 
1.1 General 
In order to treat, prevent, or slow down the progression of neurodegenerative 
diseases associated with aging of the brain, rich amounts of antioxidants such as 
polyphenols found in Vaccinium berry species have been reported to be an effective 
alternative or addition to medicinal products (Chu et al., 2011). Over the years, 
polyphenols have been credited a lot of attention due to their ability to reduce stress from 
oxidation and inflammation (Li et al., 2014), and the possible benefits they could exert on 
human health in the form of nutraceuticals. An extensive analysis of Newfoundland and 
Labrador (NL) blueberry leaves and fruits has yet to be conducted, therefore, it is 
important to analyze the neurobiological activity and biochemical constituents of 
compounds detected in Vaccinium species found here in the province. A significant 
portion of the research in our lab focuses on locally grown berries native to NL, their 
constituents, and how both the fruits and the leaves affect the neurological activity of 
specific brain cells.  According to Hirsch & Hunot (2009), many of the neurodegenerative 
conditions show neuro-inflammation, which is an inflammation that occurs in the brain 
and is a contributor to the insults in the central nervous system (CNS). Microglia, also 
known as the brains immune cells (Saura et al., 2003), are believed to play an important 
role in neuro-inflammation.  In specific neurodegenerative diseases, clusters of the 
protein α-synuclein, and excessive levels of the neurotransmitter glutamate are often 
found in the brain (Stefanis; 2012, Choi; 1988). Recent studies from our research group 
have shown that native lowbush blueberry fruits and leaves collected in NL protect rodent 
brain cells exposed to high levels of glutamate (Vyas et al., 2013b). Therefore, it is to our 
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interest to further research the in vitro models of neuro-inflammation in microglial and 
neuronal cells treated with glutamate and α-synuclein.  
 
1.2 Nutraceuticals 
Botanical nutraceuticals or drugs can be defined as materials that are plant derived 
with medicinal benefits to prevent or treat disease and exceed nutritional requirements 
(Raskin et al., 2002). Plants are considered a low-budget and safe alternative to synthetic 
sources to make nutraceutical products. Studies have shown different types of 
neuroprotective properties these supplements have contributed based on their variety at a 
metabolic and biochemical level (Mecocci et al., 2014). These include dietary 
supplements as well as synthetically made products from natural food sources. Studies on 
nutraceuticals are still emerging, being a relatively new area of research, even though 
natural derivatives of dietary products have been used for centuries as therapeutic agents.  
The use of nutraceuticals may decrease and prevent incidences of certain 
neurological conditions, along with increasing the quality and longevity of life without 
depending on expensive medication (Rahman, 2003). It is important to identify the 
components of plants that can benefit and improve neurological functions of human brain, 
as these natural sources of therapeutic agents have potential in preventing and slowing 
down the progress of neurodegeneration. For example, resveratrol, which is a non-
flavonoid polyphenol, has shown positive effects on in vivo models of neurodegeneration 
(Pirola & Frojdo, 2008). The sources of resveratrol include the seeds and skin of fruits 
such as grapes. Xu et al. (2010) showed in animal models that resveratrol increased the 
level of the neurotransmitter serotonin in the hippocampus, which is an important 
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component in mood enhancement. It was found that resveratrol inhibited noradrenaline 
and specific serotonin re-uptake in rats. This study indicates the antidepressant role 
resveratrol can play in the CNS. Another type of polyphenolics known as flavonoids, 
have also counteracted cognitive decline associated with age (Beking & Vieira, 2011). 
Due to this type of evidence, flavonoid-rich dietary interventions have emerged, including 
the tea Camellia sinensis (Chan et al., 2006) and the cocoa Theobroma cacao (Dinges, 
2006), as well as blueberry supplements (Joseph et al., 1999). These flavonoid enriched 
foods and beverages have been shown to have a beneficial effect on learning and 
memory. The catechins found in green tea (Li et al., 2009) and blueberries (Andres-
Lacueva et al., 2005) have been suggested to preserve memory and learning via kinases 
and transcription factors that play a key role in neurogenesis (Aberg et al., 2000), which 
can be defined as the procedure of generating neurons that are functional from other 
precursors (Ming & Song, 2005).  
 
 
Figure 1.1: Lowbush wild blueberry species (Vaccinium angustifolium). 
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1.3 Blueberry  
The lowbush wild blueberry species used in this study, known as Vaccinium 
angustifolium (Figure 1.1), is known to be one of the richest sources of phenolic 
compounds (Francis, 1989), with one of the highest contents of antioxidants of a variety 
of fruits and vegetables tested (Camire, 2000). The awareness of blueberry health benefits 
has expanded the blueberry industry and its products worldwide. Blueberries are now 
found as fresh, frozen, processed, dried, canned and in preserved forms (Routray & Orsat, 
2011). Fresh blueberries, in general, consist of 84% water, 9.7% carbohydrates, 0.6% 
protein and 0.4% fat (Michalska & Lysiak, 2015). Blueberries are good sources of 
polyphenols (Seeram, 2006). Huang et al. (2012) showed that the dry weight of 
blueberries contained 9.44 mg gallic acid/g of total phenolic content and a total flavonoid 
content of 36.08 mg rutin/g, which was the highest when compared to other berry fruits.   
The lowbush blueberries are also noted for their higher level of in vitro antioxidant 
capacity in comparison to highbush blueberries that have been cultivated (Kalt et al., 
1999a). External factors such as timing of harvest play an important role in the content of 
antioxidants found in blueberries. For example, depending on the cultivar and how mature 
the berries are, the outer layer thickness of a blueberry can differ greatly. Polyphenols are 
mostly located directly underneath the epidermis, an in varied amounts (Lee & Wrolstad, 
2004). It is important to analyze the different biochemical components of blueberries, as 
outlined in Figure 1.2. 
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Figure 1.2: Classification and structures of polyphenols.  
Adapted from “Dietary Polyphenols and Their Biological Significance” by Han et al., 
2007. 
 
1.3.1 Phenolics 
The structure of a phenolic compound consists of aromatic rings with one or more 
hydroxyl group attached (see Figure 1.2). There are more than 8,000 known phenolic 
structures, ranging from tannins, which are polymerized, to simple molecules known as 
phenolic acids (Dai & Mumper, 2010). Different classes of polyphenols exist based on 
their number of phenol rings and what structural element is present for binding them 
together (D’Archivio et al., 2007). Secondary metabolites, which are organic compounds 
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such as terpenes, phenolics and nitrogen containing compounds, play a key role in 
defending plants against ultraviolet radiation and parasites (Schafer & Wink, 2009). Since 
phenolics are present in most of the plant organs, they constitute a major part of plant 
foods such as fruits and vegetables, and beverages such as tea and wine (Dai & Mumper, 
2010).  
 
1.3.2 Flavonoids 
Flavonoids are polyphenols that make up a large portion of secondary metabolites, 
and the major flavonoids found in berries are flavonols and anthocyanins (Cho et al., 
2004). They consist of 15 carbon atoms and have six subgroups due to their structural 
variations, according to how the central C-ring is oxidized. They are the largest group of 
phenolic compounds that occur naturally, which act as antioxidants and protect cells from 
various forms of cell degeneration (Sulaiman & Balachandran, 2012). The common 
carbon skeleton found in flavonols include a diphenyl propane and two benzene rings 
joined together by a three carbon chain that is linear (D’Archivio et al., 2007).  Some 
common flavonoid includes catechin, measured as catechin equivilant (CE), which is 
found in tea, and cyanidin-glycoside, which is an anthocyanin of rich quantity found in 
berry fruits (D’Archivio et al., 2007). Catechin and cyanidin-glycoside are often used as a 
known standard when quantifying phenolics. Evidence suggests that consuming 
flavonoids from plant derived sources could provide protection from many adverse health 
conditions, including heart disease (Knekt et al., 1997) and stroke (Keli et al., 1996).  
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1.3.3 Tannins 
Another group of polyphenols found in the diet are tannins, which are highly 
polymerized, and consist of two types. The first type is hydrolysable tannins, which 
contain glucose and another polyol in the center, esterified with either Gallic acid or 
hexahydroxyphenic acid (Kashiwada et al., 1992). The second type is condensed tannins, 
which are also known as proanthocyanidins due to the fact that they could be broken 
down to anthocyanin through an acid-catalyzed oxidation reaction (Dávalos & Lasunción, 
n.d.). The variety in tannin structurally allows for many oxidative linkages to be formed 
(Koleckar et al., 2008). They play a role in the astringent characteristics found in fruits 
such as berries and beverages such as tea. Since proanthocyanidins have high molecular 
weight, there is potential that their absorption through the human gut may be limited 
(D’Archivio et al., 2007). 
 
1.3.4 Anthocyanins 
Anthocyanins are one of the six subgroups of plant polyphenols of flavonoids, 
also responsible for the colours found on blueberries (Veberic et al., 2009), specifically 
the red, blue and purple colour of the berries (Dai & Mumper, 2010). The colour is 
dependent on the pH; red at a pH < 2 as flavylium anhydrase forms, changing to a blue 
colour as the pH increases and quinone-type anhydro bases form, and becoming 
colourless at a high pH due to extreme alkaline conditions causing the pigment to break 
down (Chu et al., 2011). They are mainly found on the skin of fruits, where the 
anthocyanin content increases as the fruit becomes riper. Anthocyanins can scavenge 
free-radicals, chelate trace metals, and reduce deoxyribonucleic acid (DNA) oxidation 
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and degradation of lipids (Hosseinian & Beta, 2007). The anthocyanins found in the 
leaves function as a defense mechanism against photoinhibition (Hoch et al., 2001). 
Photoinhibition occurs when photosynthetic capacity decreases due to excess energy of 
carbon reduction that is utilized due to photosynthetic tissues being illuminated (Powles, 
1984). The anthocyanin levels accumulating in berries are influenced by a variety of 
factors. For example, in two consecutive harvest times, it was observed that anthocyanin 
levels fluctuated up to 30% (Kalt et al., 1999b). In some parts of the world, blueberry 
anthocyanins are produced as a food colorant (Espin et al., 2000). Anthocyanins are water 
soluble, and occur as glycosides of their aglycone form, known as anthocyanidin 
(D’Archivio et al., 2007). The content of anthocyanin can depend on environmental 
factors such as temperature, the level of nitrogen and phosphorous in the soil, and the 
amount of solar radiation it experiences (Chu et al., 2011). Blueberries contain levels of 
around 4000 parts per million of a combination of anthocyanidins, including delphinidin, 
malvidin, petunidin, cyanidin and peonidin (Aiyer et al., 2011a), as identified through 
mass spectrometry. Cyanidin is responsible for the red and purple colors, and delphinidin 
is responsible for the blue colours (Hosseinian & Beta, 2007). Lowbush blueberries 
contain anthocyanins in both acetylated and non-acetylated forms (Routray & Orsat, 
2011).   
Methods to quantify phenolic compounds in extracts from plants can depend on 
the chemical characteristic of the analyte, the standards selected and the effect interfering 
substances have on the phenolics (Naczk et al., 2006). According to Aiyer et al. (2011b), 
berries have phytochemicals that interfere with some of the pathways that can lead to 
cancer development. The estrogen receptor (ER) signalling pathway, according to Clarke 
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et al. (2001), plays a key role in breast cancer. In breast cancer diagnostics, over 70% of 
breast tumours detected are ER positive cells (Clarke et al., 2001). Antioxidants, 
specifically the anthocyanidins in berries, can lower the level of estrogen. This is done by 
binding to the ER in breast cancer cells, which reduces 17β estradiol (E2)-induced 
estrogen response elements-luciferase expression (Schmitt & Stopper, 2001), although the 
dosage, type of cell and specific anthocyanidin involved still needs to be determined. 
According to Sasaki et al. (2007), the anthocyanin; cyanidin-3-glucoside, improved cases 
of hyperglycemia by reducing the expression of retinol binding protein 4 (RBP4) in 
mouse white adipose tissue, of type 2 diabetes. This was also accompanied by the 
reduction of tumour necrosis factor alpha (TNF-α) in the white adipose tissue. Talavera et 
al. (2005), found that the anthocyanin, cyanidin 3-glucoside was capable of crossing the 
blood brain barrier in a rat diet study.  
 
1.4 Antioxidants and oxidative stress 
Oxidative stress is a condition that can occur when there are excessive free 
radicals, such as reactive oxygen or nitrogen species that overcomes antioxidant capacity 
(Dai & Mumper, 2010). When an imbalance occurs between free radical production and 
the defences of antioxidants, oxidative stress results and can be associated with damaging 
key components in the body including lipids, nucleic acids and proteins (McCord, 2000). 
Free radicals are molecules that have an unpaired electron and can exist independently. 
Many of these free radicals can donate or accept electrons from other molecules (see 
Figure 1.3), allowing them to function as either reductants or oxidants (Cheeseman & 
Slater, 1993). Many free radicals are noted to be highly reactive and capable of damaging 
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molecules such as DNA, lipids, carbohydrates (CHO) and proteins in the cellular nucleus 
and membrane (Young & Woodside, 2001). Oxidative stress and mitochondrial 
impairment are now considered to be one of the main underlying mechanisms 
contributing to neurodegeneration (Sanders & Greenamyre, 2013). 
 A stable molecule that can donate an electron to a free radical and neutralize it is 
called an antioxidant. They can do this by acting as a metal chelator, scavenge free 
radicals, inhibit enzymes and donate hydrogen or electrons (Frie et al., 1988).  
Antioxidants function to inhibit or delay damage caused to the cells by scavenging free 
radicals (Halliwell, 1995). Natural sources of antioxidants such as polyphenols are known 
to scavenge reactive oxygen species (ROS) and improve the antioxidant system in cells, 
therefore they are considered potential candidates to be neuroprotective agents (Kelsey et 
al., 2011). Studies have shown that blueberry extracts containing rich polyphenol contents 
prevented oxidative stress due to hypobaric hypoxia (Zepeda et al., 2013), which shows 
potential for people undergoing conditions that lead to oxidative stress. Antioxidants from 
both natural and synthetic sources are added to medicine and food containing oils and fats 
to protect them against oxidation, but consumer preference favored antioxidants of natural 
sources that have lower volatility and higher stability in comparison to synthetic 
antioxidant products (Papas, 1999).  Some of the proposed mechanisms of how the 
antioxidant properties of phenolics can be mediated include scavenging radicals, such as 
ROS and reactive nitrogen species (RNS), as well as inhibiting enzymes or chelating 
metals that are involved in production of free radicals and upregulating the defense 
mechanism of antioxidants (Cotelle, 2001).  
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Figure 1.3: ROS and RNS pathway in mammalian cells. Reprinted from “Antioxidants 
and free radical scavengers for the treatment of stroke, traumatic brain injury and aging” 
by Slemmer, J. E., et al., 2008. 
 
1.5 Microglia activation in the central nervous system  
The CNS has two main components, the brain and the spinal cord, which are 
responsible for interpreting sensory input and sending out commands for motor response 
based on current conditions, reflex and past experience (Marieb & Hoehn, 2007). The 
brain is composed of different cells, including neurons, astrocytes, oligodendrocytes, glia 
and microglia (Temburni & Jacob, 2001). Microglia are ovoid shaped cells that contain 
long processes that function as the immune cells of the CNS (Ghosh, 2007). When the 
brain is in a healthy state, microglial cells are described to be resting, while activated 
microglia show structural changes such as motile branching (Stence et al., 2001). 
Approximately 12% of brain cells are comprised of myeloid cells, which further develop 
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into microglia (del Rio Hertega, 1932). During a healthy state, these cells are highly 
ramified with a low profile phenotype in the adult brain (Sierra et al., 2010). When 
alterations in the environment occur causing damage to the neurons, microglial cells show 
signs of morphological change. They proliferate and become phagocytic (Saura et al., 
2003). This process is known as microglial activation, which is a response to protect the 
neural tissues (Kreutzberg, 1996). Activation can cause programmed cell death during 
brain development or when there is an injury in the CNS (Perry et al., 2010). It has been 
suggested that microglial over activation could result in increased neuronal damage 
during neurodegenerative diseases (Lull & Block, 2010).  There is also evidence 
suggesting that microglia are involved with other glial cells and neurons during activation 
(Stoll, 1999).  Since this can result in producing neurotoxic species, if microglial cells are 
chronically activated, they could contribute to the pathogenesis of disorders such as 
Alzheimer's disease (AD). Once activated, microglia can also display abnormal functional 
plasticity and transform phenotypically to macrophage-like similarities (Ghosh, 2010). 
According to Shukitt-Hale et al. (2008), when rats consumed a 2% blueberry diet over the 
span of 8 weeks after using kainic acid to induce microglial activation, cognitive 
performance had improved significantly while microglial activation decreased. 
 
1.5.1 The role of reactive oxidative speceis and cytokines in neuro-inflammation 
Neurotoxic ROS are produced by microglia through stimulating nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase activity (Block et al., 2007b). The 
polyphenols in blueberries influence activation of microglial cells both in vivo and in 
vitro. A study looked at the effect of blueberries on lesions on the brain, specifically, the 
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subcortical nuclei called the basal nuclei/ganglia. These basal ganglia are present within 
the cerebral white matter of the brain (Marieb & Hoehn, 2007).  The corpus striatum of 
the basal ganglia was induced to cause lesions in a rat study, which caused the activation 
of microglial cells. Once these rats were given a diet enriched in blueberries, results 
showed a reduction in activated microglia within the brain region (Stromberg et al., 
2005). Morphological changes in microglia include producing neurotrophic and 
neurotoxic factors such as TNF-α and ROS (McGeer et al., 2002).  
During neuro-inflammation, microglial cells are activated and pro-inflammatory 
factors (Pocock and Liddle, 2001), also known as cytokines, are released. Cytokines are 
small proteins that have various functions, including cellular communication; released for 
signalling (autocrine and paracrine) and regulating cell growth and survival (Hanisch, 
2002). Pro-inflammatory factors released by activated microglia include cytokines such as 
interleukin-1beta (IL-1β), and free radicals such as nitric oxide (NO) and superoxide, and 
studies have shown that when many of these factors are produced in excess, neurons can 
become damaged (Boje & Arora, 1992; McGuire et al., 2001). In the CNS, two key 
cytokines important for this study are TNF-α and interleukin-6 (IL-6). Cytokines 
influence the hormonal release from the adrenal or pituitary glands, which can cause 
activation of the endocrine axis by means of the hypothalamic nuclei (Turnbull & Rivier, 
1999). Functions necessary for homeostasis, such as temperature control and food 
consumption, are targets for actions produced by cytokines (Vitkovic et al., 2000). By 
releasing cytokines and other mediators, microglia could also influence communication 
between neurons of the hypothalamus and the neurosecretory cells in the signalling 
pathways between microglia and neurons (Stern & Filosa, 2013).  
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TNF-α is a ligand belonging to the TNF family, which is also known as cachectin 
(Idriss & Naismith, 2000). TNF-α is a product of dendritic cells, monocytes/macrophages 
or lymphocytes. TNF- α is an important part of inflammation and pathological conditions 
such as neurological pain, especially after injury (Hanisch, 2002). Neurological or 
neuropathic pain is recognized when nociceptive damage prolongs past the level of 
damage to the actual nerve and tissue surrounding it (Leung and Cahill, 2010). TNF-α 
mediated glutamate release has been observed from astrocytes (Bezzi et al., 2001). A 
nonpolar blueberry fraction blunts NADPH oxidase activation in neuronal cells exposed 
to TNF-α. NADPH-oxidase can cause oxidation in human neuroblastoma cells that has 
been exposed to TNF-α (Chakraborty et al., 2010).  When treated with 5 µg/ml of 
blueberry extract, research showed that oxidation levels reduced to almost control levels 
by inhibiting the assembling of NADPH oxidase enzyme (Gustafson et al., 2012).   
Expression of cytokines, along with microglia activation in the hippocampus, has 
resulted in the inhibition of proliferating neural precursors during neurogenesis (Ekdahl et 
al., 2003). This could be due to soluble factors such as IL-6 being released (Monje et al., 
2003), since the elevation of IL-6 from activated microglia has been associated with the 
disruption of neural maturation and division (Ekdahl et al., 2003). IL-6 is a pro-
inflammatory cytokine that works to coordinate an inflammatory response in order to 
limit infectious disease from spreading. In the CNS, IL-6 is involved in sleep, increasing 
pain perception and inducing fevers. During early insults within the CNS, microglia tend 
to primarily release IL-6 (Raivich et al., 1999). There is evidence to suggest that the 
immunologic response after traumatic brain injury (TBI) or stroke could be due to the 
release of cytokines as well, such as TNF and interleukins (Morganti-Kossmann et al., 
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1992; Stelmasiak et al., 2000). Since microglia are very sensitive to changing 
environments, their response to any form of infection or injury is to rapidly become 
activated. Once activated, they can upregulate surface receptors such as major 
histocompatibility complex (MHC) (Kreutzberg, 1996). The role microglial cells play in 
immune surveillance is important, as they present antigens of MHC class II that are 
expressed to cluster of differentiation-4 (CD-4) positive T cells, and have similar antigens 
with hematopoietic macrophages (Fedoroff et al., 1997).  
 
1.5.2 Pathological conditions associated with microglial activation 
Aspects of cognition that are influenced by nutrition include many neurological 
disorders, such as AD and Parkinson's disease (PD), (Associate Parliamentary Food and 
Health Forum, 2008). Specific nutritional components such as antioxidants, have been 
considered one approach for slowing down the progression of AD (Swaminathan & Jicha, 
2014). Initially based on a post-mortem analysis of the brain of patients with AD and PD, 
it was suggested that microglial activation was involved in these neurodegenerative 
diseases (Liu & Hong, 2003).   
According to Arendt (2001), people with AD show unusual production levels of 
amyloid precursor proteins (APP), which progresses into amyloid beta (Aβ) aggregation 
forming plaques which is a predominant hall mark of AD. Evidence suggests that 
activated microglia were present in the cortical regions of AD brains, co-localizing with 
neuritic plaques (Rogers et al., 1988). According to Paulson et al. (2008), this disease is 
characterized by neurofibrillary tangles, synapse loss, and the hallmark trait of Aβ peptide 
deposits. The Aβ peptides stimulate microglia, which produces factors such as TNF-α 
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which causes a neurotoxic cascade which tends to recruit more microglia (Hanisch, 
2002). The brains of AD patients have shown a large amount of inflammation, where 
cytokines such as IL-6 and TNF-α have been detectable in the brain tissue, postulated to 
cause neuronal structure loss (Akiyama et al., 2000). Also, patients under nonsteroidal 
anti-inflammatory drug treatment were observed to have a lower prevalence of AD 
(McGeer & McGeer, 1999; Akiyama et al., 2000). Cytokines such as IL-1 and TNF-α 
causing inflammation can further increase the progression of AD (Perry et al., 2001), 
which shows the relationship between the pro-inflammatory factors released by 
microglial cells and the development of AD.  
PD is characterized by symptoms such as tremor and rigidity (de Lau & Breteler, 
2006).  The pathological characteristics of PD include the dopaminergic neurons 
decreasing in the substantia nigra pars compacta (SNpc) and activated macrophages 
(Lowe & Leigh, 2002), along with Lewy bodies, which are inclusion bodies present 
intracellularly, surrounded by α-synuclein aggregates (Matsumoto et al., 2010). Early 
onset and familial PD is seen in a small faction (<5%), and most clinical symptoms and 
sporadic cases of PD usually progress over the later decades (Olanow & Tatton, 1999). In 
PD, activated microglia and other inflammatory mediators are shown to surround nigral 
aggregates, which are immunoreactive to α-synuclein (Yamada et al., 1992). Pro-
inflammatory cytokines could also play a role, as Wahner et al. (2007) found that the risk 
of developing PD doubled for patients if they carried the homozygous variant genes of 
TNF-α position -308, and the susceptibility of PD could be influenced by the 
polymorphism of the TNF-α gene.  
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1.5.3 Inducers of neuroinflammation: α-synuclein and glutamate 
α-synuclein is part of the family of synuclein neuronal proteins that localize 
predominantly to the presynaptic terminals (George, 2002), which is found in the 
pathogenesis of PD and other disorders related to neurodegeneration. PD patients have 
shown accumulation of nigral aggregates and Lewy bodies, immunoreactive to the protein 
α-synuclein, which were often present and surrounded by activated microglia (Yamada et 
al., 1992). Lewy bodies are cytoplasmic inclusions that are characterized in PD patients. 
It has been suggested that microglia activation in PD patients could be due to α-synuclein 
aggregates released from dopaminergic neurons that are dying, which could potentially 
initiate inflammation in order to eliminate α-synuclein that is released (Zhang et al., 
2005).  
Glutamate is an important excitatory neurotransmitter in the mammalian nervous 
system, and increases during conditions such as TBI in vivo (Palmer et al., 1994). 
According to Purves et al. (2001), glutamate is a neurotoxic substance, which acts on 
metabotropic and ionotropic receptors. These include Kainate and 2-amino, 3-(3-
hydroxy- 5-methylisoxazol-4-yl) propionate (AMPA) receptors, all non-selective cation 
channels that allow K+, Na+ and sometimes Ca2+ to pass through (Purves et al., 2001). 
Glutamate also acts on neurons via N-Methyl-D-aspartate receptor (NMDA) receptors 
which results in an increased calcium influx and cell death (Blanke & VanDongen, 2009). 
Neurotoxicity mediated by glutamate has been observed in neurodegenerative conditions 
such as brain injury (Hanisch & Kettenmann, 2007). Since glutamate is known to activate 
receptors such as calcium permeable ion channels (Weber, 2012), cell cultures derived 
from rodent brains have undergone glutamate induced toxicity, where these neurons and 
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glial cells were damaged by an increased stimulation from neurotransmitters such as 
glutamate (Vyas et al., 2013). This process mimics the pathology of neurodegenerative 
disorders by inducing nitrosative and oxidative stress (Slemmer et al., 2008). Excess 
glutamate, produced due to synaptic activity is usually taken up by astrocytes under 
normal conditions. When certain pathological conditions occur, the uptake of glutamate 
by astrocytes is impaired (Persson et al., 2005). The term “excitotoxicity”, which was 
labelled by Olney (1969), is the process of glutamate being released in large amounts and 
overstimulating amino acid receptors that are excitatory. This excessive glutamate release 
is observed in cell death and injury of the CNS (Lau & Tymianski, 2010). After injury, 
there can be an elevation in calcium due to leakage via damaged cell membranes or 
voltage gated calcium channels being activated (Young, 1992). When free calcium levels 
are increased, it can cause the activation of enzymatic reactions which can eventually 
cause cell death (Wojda et al., 2008), and this may be an important mechanism that 
influences secondary damage to neurons after insult to the brain (Weber, 2012).  
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1.6 Hypotheses: 
Based on biochemical assays and high performance liquid chromatography mass-
spectroscopy (HPLC-MS) analysis for blueberry fruits and leaves, I hypothesize that 
blueberry leaves will have higher amounts of polyphenolics (flavonoids, tannins) and 
anthocyanins than fruits. I also hypothesize that due to past literature supporting the 
ability of anthocyanins to cross the blood brain barrier, blueberry fruits and leaves 
will have a neuroprotective effect on microglia cells by reducing the amount of 
activation induced by glutamate and α-synuclein, and by sustaining healthy microglia 
cells. 
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1.6 Objectives of the study 
The purpose and aims of this research project are: 
- To conduct extractions and assays of blueberry fruits and leaves from seven 
different locations within St. John’s and the surrounding area in order to 
investigate overall levels of polyphenols and their biochemical activity. 
- To perform a pilot study to determine if polyphenols, specifically the 
anthocyanins in blueberries can cross the blood brain barrier of mice at a 
detectable level. 
- To quantify and identify major anthocyanins detected in blueberries and mouse 
tissue using HPLC-MS.  
- To determine the potential neuroprotective effect that blueberries have on the 
inflammatory response mediated by microglia, after induction with glutamate or 
α-synuclein. 
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Chapter 2: Materials and Methods 
2.1 Plant extraction procedure 
2.1.1 Collection and storage 
For this project, the material used for fruit and leaf studies included wild lowbush 
blueberries (Vaccinium angustifolium). The blueberry fruit and leaf samples were 
collected from seven different sites, including Pippy Park, Signal Hill, Johnson Geo 
Centre, Fort Amherst, Blackhead, Marine Drive and Middle Cove in NL during the month 
of September, 2014 (See Figure 2.1 and Table 2.1). Blueberry fruits and leaves were 
harvested and stored at -20°C within the first hour of collecting, then after 40 minutes, 
transferred to a -80°C freezer for storage to prevent degradation of phenolic compounds, 
since past literature found that phenolic content can remain the same or even increase in 
cold storage, depending on the cultivar (Connor et al., 2002). 
 
Table 2.1: Geographical information on collection sites of Newfoundland blueberry 
fruits and leaves 
 
Location Legend from 
Figure 2.1 
Latitude Longitude 
Signal Hill  47.5701° N 52.6819° W 
Johnson Geo Center  47.5730° N 52.6900° W 
Blackhead  47.5299° N  52.7094° W 
Fort Amherst  47.5635° N 52.6825° W 
Pippy Park  47.5824° N 52.7333° W 
Marine Drive  47.6622° N 52.7097° W 
Middle Cove  47.6404° N 52.6865° W 
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Figure 2.1: Collection sites of wild Newfoundland blueberry fruits and leaves 
Image modified from Google Maps (2016). Blueberry collection site represented by  
Legend is available on Table 2.1.  
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2.1.2 Fruit and leaf extraction to determine phenolic compounds 
Fruit extraction 
A stock solution was prepared consisting of 80% (v/v) acetone with 0.2% formic 
acid and 19.8% distilled water (dH2O). Based on past literature, these solvents were 
determined to be the best extract solvent when compared to various mixtures of solutions 
(Vyas et al., 2013a). Blueberry fruits were grinded using a mortar and pestle. Since 
weight of specific sample varied slightly, in order to have a consistent concentration, a 
stock solution was added to blueberry fruits at a ratio of 1:2. This mixture was then 
vortexed to homogenize, then shaken on ice for 30 minutes. The solution was then 
centrifuged at 20 000 G (gravitational force) for 20 minutes at 4℃ and the supernatant 
was collected. The entire procedure was repeated using the residue pellets, then 
supernatants combined. The final concentration was further adjusted to give 250 mg/ml 
solvent of fresh weight, which is the weight of the specimen including its water content.  
Leaf extraction 
Liquid nitrogen was added to the leaf sample, followed by grinding to fine 
powder. Liquid nitrogen was used due to the efficiency of breaking down the tough 
cellulose structures in the leaves, compared to other methods of grinding the sample. The 
above stock solution was added to leaf samples at a ratio of 1:2, vortexed to homogenize, 
then shaken on ice for 30 minutes. The mixture was then centrifuged at 20 000 G for 20 
minutes at 4℃ and the supernatant was collected. The entire procedure was repeated 
using the residue, and then supernatants combined. The sample was then diluted, giving a 
final concentration of 25 mg/ml of fresh weight. 
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2.2 Blueberry biochemical assays  
Leaf and fruit extracts were diluted an additional 10X for this portion of the 
experiment, to a final concentration of 25 mg/ml of fruit and 2.5 mg/ml of leaf fresh 
weight. All biochemical experiments were replicated three times.  
 
2.2.1 Total soluble phenolic content  
Colorimetric reactions using the Folin-Ciocalteu method was used to quantify the 
polyphenols in both fruits and leaves as outlined by Vyas et al. (2013b). The polyphenols 
react with Folin-Ciocalteu reagent, a redox reagent, to form a blue color complex that can 
be quantified by a spectrophotometer. This was done by using phenolate ion to reduce the 
phosphotungstate-phosphomolibdenum complex to change the colour to blue. When the 
sample extract consists of more phenolics, this reduction process increases, which causes 
the blue colour to become darker and increase the absorbance value (Arbianti et al., 
2007). 500 µl of Folin-Ciocalteu reagent was added to 500 µl of 2.5 mg/ml of leaf or 25 
mg/ml of fruit sample and vortexed. In order to neutralize the reaction, 1 ml of saturated 
sodium carbonate solution was added to a final volume and was adjusted to 10 ml with 
dH2O, then vortexed for 30 seconds. The mixtures were then incubated in the dark for 35 
minutes at room temperature, centrifuged at 4000 G for 10 minutes, and the absorbance 
was read on a spectrophotometer at 725 nm. The total phenolic content (TPC) was then 
determined using Gallic acid as a standard and expressed as GAE or ‘Gallic Acid 
Equivalents’ (Blainski et al., 2013). The unit of measurement was expressed as 
milligrams of GAE per gram of sample fresh weight.    
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2.2.2 Total flavonoid content  
Flavonoid content is measured using an aluminum chloride colorimetric assay as 
outlined by Vyas et al. (2013b). One ml of sample or standard solution of catechin (0.5 
mg/ml) was added to 0.3 ml of 5% NaNO2. After 5 minutes, 0.3 ml of 10% aluminum 
chloride (AlCl3) was added and after 1 minute, 2 ml of 1 M NaOH was added and 
adjusted with 24 ml of dH2O. This was vortexed and incubated in the dark for 15 minutes 
at room temperature and centrifuged for 5 minutes at 4000 G. The absorbance was 
measured at 510 nm and the total flavonoid content (TFC) was expressed as μmol of CE 
per gram of sample.  
 
2.2.3 Total tannin/ proanthocyanidin content 
This assay uses vanillin as a reagent which reacts with the A-ring of flavonols, 
forming a chromophore. The absorbance in the solution is directly proportional to the 
number of flavonols present (Waterman & Mole, 1994). The structure of vanillin consists 
of an aromatic aldehyde that reacts with the ring structure of flavonols from the extract to 
yield a red colour product. According to the method developed by Chandrasekara and 
Shahidi (2011), one ml of sample was added to 5 ml of 0.5% vanillin-hydrogen chloride 
(HCl) reagent and incubated in the dark for 20 minutes. The standard used was catechin 
(Price et al., 1978). The absorbance was read at 500 nm, and total tannin content was 
expressed as µmol of CE per gram of sample. 
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2.2.4 Total antioxidant capacity  
Total antioxidant capacity was determined using the 2, 2-diphenyl-1-
picrylhydrazyl (DPPH) assay, which is a stable free radical that is violet in colour, 
adopted from the protocol outlined by Brand-Williams et al. (1995) with some 
modifications (Vyas et al., 2013b). When DPPH solution is dissolved with a substance 
that can donate a hydrogen atom, it yields a reduced product, indicated by the loss of 
violet colour originally present in DPPH solution. This method can be used to assess the 
properties of parts of plants that can scavenge free radicals. This procedure is dependent 
on the spectrophotometric measurement of DPPH concentration changes that occurs due 
to a reaction with an antioxidant (Pyrzynska & Peka, 2013). A sample unit of 100 µl was 
added to 1900 µl of 0.06 mM of DPPH stock and vortexed. This was incubated in the 
dark for 20 minutes and read on the spectrophotometer at 515 nm. The unit of 
measurement for scavenging capacity was expressed as ‘% of inhibition of DPPH 
consumption’ and the results were expressed as GAE against the Gallic acid standard 
curve.   
 
2.3 Bioavailability of blueberry polyphenols in mice (pilot study) 
The mice used in this study were of the C57bl/6 strain purchased from Charles 
River Laboratories and housed under standard conditions (12 hour light and 12 hour dark 
cycle). They were 7 week old males, weighing between 20-22 grams initially, with a total 
of 18 mice. The experiment was conducted at the Health Sciences Centre (HSC) Animal 
Care facility, and all procedures using mice were approved by the Institutional Animal 
Care Committee of Memorial University of Newfoundland (MUN). Mice were 
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acclimatized for 5 days, and were given standard mice chow and water for the entire 
study. They were housed in cages consisting of three mice per cage, and divided into 
three groups consisting of 6 mice. The three diet groups were control, leaf and fruit, all 
administered via oral gavage.   
 
2.3.1 Sample extraction for leaves and fruits for mice feed 
Frozen berry fruit or leaf samples of 20-30 grams were used to feed mice directly 
via oral gavage. Leaf and fruit samples were thawed at room temperature, then 
homogenized into a fine paste. The extraction procedure used different solvents in diet 
study compared to other experiments. In order to extract fruit and leaf extract for diet 
study, only dH2O was used to dilute the concentration, since we did not want other 
chemicals to cause unnecessary side effects in our mice during the diet study. According 
to previous studies (Andres-Lacueva et al., 2005; Kalt et al.; 2008, Milbury & Kalt, 
2010), we adjusted the solution to 2% fruit extract using dH2O as the solvent. Since our 
earlier biochemical analysis results showed that 10 times the polyphenolic content was 
found in leaves compared to plants, we determined 0.2% leaf extract should be used. 
Homogenate was placed in a syringe and supernatant filtered into a clean vial using a 0.45 
µm filter, since that allowed for extracts to be small enough to pass through the syringe 
during oral gavage.  
 
2.3.2 Monitoring  
Via oral gavage, 0.1 ml of the 2% berry or 0.2% leaf extract was administered to 
the mice every day for 14 days around 10 am. The control mice were given 0.1 ml of 
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dH2O in place of extract. The mice were monitored for those 14 days consecutively, 
where mice were weighed on a daily basis, and consumption of food and water was 
monitored.   
 
2.3.3 Dissection and organ extraction  
The food was removed from each mouse 4 hours prior to surgery. The 
anesthetization procedure involved placing a mouse into a sealed container with a paper 
towel lightly soaked with halothane/isoflurane. In order to ensure full anesthetization, 
tapping the mouse on the eye to ensure the blink reflex was suppressed, was performed 
after one minute of anesthetization. Mice were decapitated around the same time of day 
using an animal guillotine and organs of interest extracted included the brains (cortex and 
cerebellum), right and left kidneys, heart, and liver (in HSC 3415, with protocols 14-24-
JW and 15-31-JW). All organs were placed in a liquid nitrogen bath for 1 minute to be 
flash frozen, put into labeled tubes and placed into a -80 °C freezer until use.  
 
2.4 HPLC and MS Analysis of berries and mouse organs  
In order to determine which anthocyanins were present in the leaf and fruit 
extracts, and if they were absorbed and detectable in the mouse organs after consumption, 
a HPLC-MS analysis was conducted. We chose to focus on anthocyanins because we 
found that past experiments in our lab were able to detect them in different local berries 
and we wanted to narrow down the compounds available in blueberries native to NL. In 
order to quantify the amount of certain anthocyanins detectable in the leaves, fruits, and 
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mouse organs, two standards of known anthocyanins were used: delphinidin 3-0- 
glucoside and cyanidin-3-galactoside. 
 
2.4.1 Extract preparation for HPLC  
Preparation of extracts was performed using methods outlined by Cho et al. 
(2004) with modifications. Berry samples were homogenized into paste using a mortar 
and pestle. Leaf samples were ground into a fine powder using liquid nitrogen. 
Homogenate was placed into a lyophilizer and freeze-dried overnight until dehydrated. 
Twenty mL of extract-ion solution (methanol/water/formic acid 60:37:3 v/v/v) was mixed 
with 5 grams of fruit/leaf powder. This mixture was then sonicated for 30 minutes in a 
water-bath sonicator, and then centrifuged at 2600 G for 30 minutes at 4°C. A 4 mL 
aliquot of the supernatant was collected and placed in a rotary evaporator at 45 °C until at 
least 95% of extract solvent was removed. The sample was then re-suspended in 1 mL of 
3% formic acid in water solution and filtered through a 0.45 µm pore filter.  
 
2.4.2 Standard and calibration curves  
Two grams of anthocyanin reference standards (delphinidin 3-0-glucoside and 
cyanidin-3-galactoside) was dissolved in 10 mL of 3% formic acid to make a final 
concentration of 200 µg/ml. Serial dilutions were conducted to obtain concentrations of 
150 µg/ml, 100 µg/mL, 50 µg/mL, and 25 µg/mL and 12.5 µg/mL of the reference 
standard stock solutions. Each standard solution was injected separately under the same 
HPLC conditions in order to create calibration curves for the reference compounds. The 
aim was to generate a linear calibration curve with R2≥0.98.  
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2.4.3 HPLC parameters 
An Agilent 1100 Series HPLC system equipped with a G1311A quaternary pump 
(Serial Number DE40926119) was used. Fruit and leaf extracts from two locations, which 
showed the highest levels of polyphenols in the biochemical analysis, were injected 
(about 15 µl) into the HPLC system. Separation was conducted using a 3.9 mm x 150 mm 
C18 (5μm) column. Prior to each injection, the system was equilibrated for 20 minutes. A 
Diode Array Detector (DAD) was used to detect flavonols at 360 nm and anthocyanins at 
520 nm. The liquid chromatography flow rate was at 0.8 ml/min and the temperature was 
at 25 °C. The mobile phase consisted of a linear gradient of 5% formic acid (A) and 
methanol (B) from 2% methanol to 60% methanol for 60 min at a rate of one ml/min.  
 
2.4.4 MS parameters 
The parameters for MS were similar to the design developed by Cho et al. (2004), 
where both positive and negative electrospray ionization (ESI) were utilized. The 
capillary voltage was 4.0 kV, nebulizing pressure of 30.0 psi, temperature of 300 °C, 
drying gas flow rate of 9.0 ml/min. The performance was at 1.0 second/cycle with a 
scanner mass range of 10-1000 m/z (mass/charge). For identification, HPLC 
chromatographs and their MS values were compared to values accessible in the literature.  
 
2.4.5 Tissue sample preparation for HPLC analysis 
A stock solution was prepared of acidified methanol, using methanol (80% v/v), 
acetic acid (2.5% v/v) and ascorbic acid (15% v/v), adjusted with dH2O. The volume of 
this stock solution differed based on the organ and the weight of the organ. The extraction 
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procedure used different solvents compared to extraction procedures for other portions of 
this project due to the fact we were using animal tissues instead of plant tissues, therefore 
different solvents used in past literature were observed to be effective. The animal tissues 
were weighed, and minced ground using a glass mortar and pestle. Depending on the type 
and weight of tissue, the amount of stock solution added differed. For one gram of brain 
tissue, 4 ml of acidified methanol solution was added to grind the organ and collect the 
residues on the glass vase and homogenizer. For one gram of liver, lungs, kidneys, 2 ml 
of acidified methanol was added to homogenize the mixture and an additional 2 ml to 
clean the homogenizer, making up a final volume of 4 ml. The sample was transferred 
into a 10 ml conical glass tube and vortexed for 5 minutes, then it was centrifuged at 3000 
G for 30 min at 4°C. The supernatant was transferred into a clean tube, then the procedure 
was repeated two more times to extract the leftover residues with 4 ml acidified methanol 
and vortexed for 5 minutes. The mixture was again centrifuged at 3000 G for 30 min at 
4°C. In order to evaporate the organic solvents, a rotary evaporator was used to yield a 
final volume of 400 µl, and placed in a seal amber vial for HPLC analysis. 
 
2.5 Cell culture experiments 
2.5.1 Microglial cell culture process  
Microglia were purchased from ScienCell Research Laboratories (Carlsbad, CA, 
USA) which were isolated from postnatal day two C57BL/6 mouse brains, and 
cryopreserved and frozen prior to use at the HSC.  
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Microglia medium  
Microglia medium (ScienCell) was prepared at the HSC cell culture lab, which 
consisted of 500 ml of sterile basal medium (MACS Neuro Medium), 5 ml microglia 
growth supplement, 25 ml of bovine serum and 5 ml of penicillin/streptomycin solution, 
and stored at 4ºC. 
Poly-L-ornithine  
In order to promote cells to adhere to the culture wells for the first set of 
experiments, Poly-L-Ornithine (PLO-500ug/ml; Sigma), was used to coat in 12 of the 
wells in 24 well plates. Two types of plates were used; Falcon® and Costar®.  
PLO coating solution  
A PLO solution was prepared using 10 ml of distilled water added to 100 mg of 
PLO in order to get 10 mg/ml of solution. From this solution, 300 µl was placed in 1.5 ml 
centrifuge tubes and stored at -80°C. The coating solution was made by adding 5.7 ml of 
distilled water to 300 µl of PLO, to make a PLO concentration of 500 µg/ml solution, 
then vortexed. For the 24 well polystyrene plates, 12 wells received 250 µl of coating 
solution. The culture plates were coated in half of the wells a day prior to cell culture 
experiments, and incubated at 37°C in a humidified incubator with 5% carbon dioxide 
(CO2).  
Culturing cells 
In the first experiment, the PLO was rinsed twice with 0.5 ml of sterile water per 
well the following day, and 1 ml of microglial medium was added to each well. Primary 
microglial cells were plated (20 µl per well) at a seeding density of ≥10,000 cells/cm2 per 
well in a 24 well plate, in both PLO coated and uncoated plates. After the first set of 
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treatments, wells were no longer treated with PLO explained further in the ‘Discussion’ 
section. In the second set of experiments, the plates were coated at a seeding density of 
≥30,000 cells/ cm2 per well, with 27.8 µl per well. The most recent set of experiments had 
a seeding density of ≥43,000 cells/cm2 per well, with 40 µl of cells per well.  
The culture was left undisturbed in the incubator for 24 hours after initiation, and medium 
was changed the next day (by removing 1 ml of old media and replaced with 1ml of fresh 
media) to remove the residual preservative; dimethyl sulfoxide (DMSO) and unattached 
cells from the culture. Media was then refreshed every other day (0.5 ml of media 
replaced) until treatment experiments started.  
 
2.5.2 Cell treatments 
Once microglial cells were plated in wells and progressed to more elongated cells, 
they were treated with various conditions. From each final stock solution, 500 µl was 
administered to the treatment well. Blueberry fruit and leaf extracts collected from Pippy 
Park, which were tested in all biochemical assays, were used in all treatments in cell 
culture. Stock solutions of the following conditions were first made: solvent, control, 10 
µM glutamate, 100 µM glutamate, α-synuclein, glutamate and fruit, glutamate and leaf, α-
synuclein and fruit, and α-synuclein and leaf.  
Solvent treatment 
In order to ensure the solvent from the blueberry extracts had no effect on the cells 
before treatment with blueberries, the solvent alone was used to treat the cells in the first 
few experiments. The solvent consisted of 80% acetone and 0.2 % formic acid and 19.8% 
dH2O and filtered.  
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Control treatment 
A stock solution of 2.0 ml media was added to 25 µl of dH2O and 2.5 µl of solvent 
treatment.   
10 µM glutamate treatment 
For some of the earlier set of experiments, this concentration of glutamate was 
also used to find an optimal glutamate concentration causing neuro-inflammation. 2.5 µl 
of the 10 mM L-glutamic acid stock solution was added to 2.5 ml of the culture media per 
well to get a final concentration of 10 µM.  
100 µM glutamate treatment  
A stock solution of 10 mM glutamate was made, where 10 ml of sterile dH2O was 
added to 14.7 mg of L-glutamic acid (Research Biochemicals Inc.) and filtered. 25 µl of 
10 mM stock solution was placed in 2.5 ml of media in the culture well, which gave a 
final concentration of 100 µM. 
α-synuclein treatment 
A stock solution of α-synuclein was made by dissolving 100 µg/ml of α-synuclein 
into 5 ml of dH2O. 2.5 µl of this stock solution was added to 2.5 ml of microglia media to 
yield a final concentration of 100 ng/ml.  
Glutamate and blueberry fruit treatment 
Twenty µl of the 10 mM L-glutamic acid stock solution was added to 2 ml of the 
culture media and 1 µl of blueberry sterile filtered fruit extract per well, giving a final 
concentration of 12.5 µg/ml for fruit extracts.   
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Glutamate and blueberry leaf treatment 
Twenty µl of the 10 mM L-glutamic acid stock solution was added to 2 ml of the 
culture media and 1 µl of blueberry sterile filtered leaf extract per well.  This gave a final 
concentration of 1.25 µg/ml for leaf extracts.  
α-synuclein and blueberry fruit treatment 
Two µl of the α-synuclein stock solution was added to 2 ml of the culture media 
and 1 µl of blueberry sterile filtered fruit extract per well.   
α-synuclein blueberry leaf treatment 
Two µl of the α-synuclein stock solution was added to 2 ml of the culture media 
and 1 µl of blueberry sterile filtered leaf extract per well.   
All stock solution of different treatments was then vortexed and incubated in the water 
bath (37°C) for 10 minutes. Old media was removed and each well was given 0.5 ml of 
specified treatment.  
 
2.5.3 Cell culture staining and immunolabeling  
The cells were all treated for 24 hours in appropriate treatment conditions, then 
culture media was removed from all treated wells. The media from each well was saved 
in separate Eppendorf tubes and stored at -80°C. All chemical solutions used in this part 
of the experiment is further explained in Table 2.2.  
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Table 2.2: Chemical preparation and purpose for fixing and staining cultured cells 
Chemical Preparation and use/purpose 
0.2 M Phosphate 
Buffer 
 
 
 
 
In order to make 4 litres of this solution, 92 grams of sodium 
phosphate dibasic was added to 20.96 grams of sodium 
phosphate monobasic. These chemicals were dissolved in 3.8 L 
of dH2O, pH was adjusted to 7.4 using 10 N NaOH (in order to 
increase pH) or concentrated HCl (in order to decrease pH). In 
order to top up to a final volume of 4000 ml, dH2O was added. 
Phosphate Buffer 
Solution (PBS) 
In order to make 1 litre of this solution, 500 ml of 0.2 phosphate 
buffer was added to 500 ml of dH2O and 9 grams of NaCl.  
Paraformaldehyde 
Fixative (PFA)  
 
In order to prepare this fixative, 400 ml of dH2O was placed in 
a 1000 ml beaker and heated to 70°C under the fume hood.  
Then we added 40 grams of PFA and solution was stirred until 
no longer cloudy in appearance. The solution of 10 N NaOH, 
which was cold, was added by drops until the solution became 
clear, then 500 ml of 0.2 M cold Phosphate buffer was added. 
In order to bring the final volume to 1000 ml, dH2O was added 
to the solution, making a final concentration of 4% PFA. Using 
a bottle filter, the solution was filtered and stored at 4ºC.    
Blocking Solution This solution contained 2 grams of 2% Bovine Serum Albumin 
(BSA) combined with 2 ml of 2% Fetal Calf Serum (FCS), 200 
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mg of 0.2% fish skin gelatin and 98 ml of PBS. This was stirred 
for one hour, and stored at 4ºC.  
Antibodies The primary antibodies (Ab) used in our experiment include 
F4/80, Iba-1 and glial fibrillary acidic protein (GFAP) 
antibodies. F4/80 and Iba-1 antibody binds to microglial cells, 
which expresses antigens on the microglial cell surface. GFAP 
is expressed by astrocytes, and used in this project to determine 
if any astrocytes are present in the cell culture. Secondary 
antibodies include Goat anti-rabbit Alexa Fluor® 488 which 
fluoresces green and conjugated goat anti-mouse Alexa 
Fluor®594 which fluoresces red.  
Antibody Solution 1  
 
This solution contained 1.125 ml of PBS, 0.125 ml of Bovine 
Serum (BS), 25 µl of F4/80 and 5 µl of GFAP or 
2.7 ml PBS, 0.3 ml BS, 6 µl Iba-1 Ab.  
Antibody Solution 2  
 
This solution contained 1.125 ml of PBS, 0.125 ml of BS, 4.2 
µl of F4/80 and 2.5 µl of GFAP.   
Antibody Solution 3 
 
This solution contained 3.825 ml of PBS, 0.425 ml of BS, 14.2 
µl Alexa 488 (fluorescing green) and 14.2 µl of Alexa 594 
(fluorescing red).  
 
The wells were washed twice with 0.5 ml phosphate buffer solution (PBS) (pH 
7.4). Then 300 µl of 4% paraformaldehyde (PFA) fixative solution was added to each 
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well, and removed after 20 minutes. Cells were then permeabilized using 0.2 % Triton X-
100 (Sigma), and the solution was removed after 10 minutes. Cell wells were washed 
once with PBS, then incubated with blocking solution (250 µl per well), which coats cells 
in order to block non-specific binding. The blocking solution was removed after 30 
minutes, and specific wells were incubated with 250 µl of primary antibody for one hour, 
then the solutions were removed. The cultures were washed twice with PBS, then 
incubated with secondary antibody solution (250 µl per well) in the dark for one hour. 
The remaining protocols for the experiment were conducted under the dark fume hood. 
After solution was removed, cells were washed with 0.5 ml PBS two times, then 
dehydrated with 250 µl of 70% ethanol, followed by dehydration with 250 µl of 100% 
ethanol to remove all excess moisture. Approximately 15 µl of VectaShield mounting 
medium with the fluorescent stain 4', 6-diamidino-2-phenylindole (DAPI) was added to 
wells, which binds to adenine-threonine regions in DNA. This stain can be used to label 
live and fixed cells due to its ability to pass through the cell membrane.  The cells were 
covered with glass cover slips and stored at -20°C.  
All images of cells were captured using a Zeiss Observer A1 microscope, Pixelfly 
qe CCD camera at a magnification of 40X (pco, Kelheim, Germany) and Axiovision 
software. The images were taken from 5 different sections of the well, then the cells 
counted manually. The differential interference contrast microscope was used to observe 
the morphology of cells in various treatments by capturing light microscopy images.  
Images were also captured using a confocal microscope by Dr. Noriko Daneshtalab using 
16 well slides. The same procedures were followed for cells on slides, with the exception 
of the amount. 100 µl of media and 8.7 µl of cells were plated per well, and each well was 
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given 100 µl of target treatment. During the staining and fixing procedure, 100 µl all 
solutions were given per well.  
Immunocytochemistry 
In order to quantify the cell death of microglial cells, immunolabeling using F4/80 
and GFAP was conducted (Weber et al., 2012), Along with this, overall cell counting was 
performed which was determined by DAPI staining, using the program Axiovision.  
Experimental changes: 
Poly-L-Lysine (PLL) has a positively charged amino acid chain that improves 
adhesion of cells by changing the surface charges on the substrates of the culture 
(Cornbrooks, 1986), and it was recommended to use this instead of PLO as a coating 
agent to promote the adhesion of cells in culture. It is also encouraged to use this surface 
treatment to increase the survival rate of primary cells in culture.  F4/80 was substituted 
by Iba1 Ab in later experiments, due to this new Ab labelling the cells better and giving a 
stronger fluorescence. Primary Ab solution now contained 0.3 ml of BS, a 2.7 ml of PBS 
and 6 µl of Iba1 Ab. Secondary Ab solution contained 0.35 ml of BS, 3.15 ml PBS and 
11.7 µl of Alexa 488 (goat anti-rabbit).  
In experiment 5, Vectashield was not available, so cells were mounted using 50/50 
glycerol and dH20. The primary antibody consisted of 3.6 ml PBS, 0.4 ml BS and 20 µl 
F4/80 Ab and the secondary Ab consisted of 4.05 ml tris-base saline (TBS), 0.45 ml BS 
and 15 µl of Alexa 594 anti-rat Ab and 3 µl of DAPI. 
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2.6 Statistical analysis 
The experiments for biochemical analysis were all repeated three times and the 
results are expressed as mean ± standard error (SE) of all three replicates. Using two-
sample assuming unequal variance t-test (Microsoft Excel), statistically significant 
differences were determined between fruits and leaves. One-way ANOVA and Duncan’s 
Multiple Range Variance Test (SPSS 39, IBM Inc.) were used to determine differences 
between different locations. The cell culture experiments were analyzed with one-way 
ANOVA (P < 0.05) followed by the post hoc Tukey’s Multiple Comparison Test (SPSS 
39, IBM Inc.). Results are expressed as means ± SE. 
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Chapter 3: Results 
3.1 Biochemical assay of blueberries collected from various sites 
In order to determine and identify the levels of phenolic content of different 
samples collected from various locations, and to directly compare the fruits with the 
leaves from each location, different phenolic tests were conducted. Fruit samples from 
Middle Cove, Signal Hill and Johnson Geocentre were not tested because during the time 
of sample collection, there was a limited amount of healthy berry fruits available from 
these specific locations. Although locations were chosen within St. John’s and 
surrounding area, it gave us a perspective on the variety of phenolic compounds that can 
exist within a similar region due to genotype and environmental factors. Each 
biochemical assay experiment was graphed to show the overall comparison between 
leaves and fruits, then individually graphed based on location to show the various 
significant difference amongst fruits or leaves collected from locations that were 
geographically close together, yet provided significant differences in phenolic content.  
The leaves, overall, had a higher content than fruits of lowbush blueberries when 
assessing the total phenolic content (Figure 3.1), the total flavonoid content (Figure 3.2), 
total tannin (Figure 3.3) and total antioxidant content (Figure 3.4). The only exception to 
this trend was found in berries from Blackhead, in which the fruits had higher tannin 
content than leaves (Figure 3.3). When measuring the total soluble phenolics, leaf extracts 
from Pippy Park (Figure 3.1.1) and fruit extracts from Marine Drive showed the highest 
soluble phenolic content (Figure 3.1.2). Fruits from Pippy Park (Figure 3.2.1) and leaves 
collected from Pippy Park (Figure 3.2.2) had the highest content of flavonoids. Leaf 
samples collected from Pippy Park (Figure 3.3.1) and fruits collected from Marine Drive 
42 
 
(Figure 3.3.2) had the highest tannin levels. The total antioxidant capacity was the highest 
in leaves collected from Signal Hill (Figure 3.4.1) and fruits collected from Fort Amherst 
(Figure 3.4.2). All overall significant differences determined between leaves and fruits 
were analyzed by using two-sample T-test assuming unequal variances (P< 0.05). The 
significant differences between samples of different locations was calculated by One-way 
ANOVA, followed by Duncan’s Multiple Range Test (Table 3.1 and 3.2) . Data are 
expressed as mean ±SE; where experiments were performed with three replicates.Within 
the same column, different letters (a,b,c,d,e) indicate statistical significance at P < 0.05. 
Values represented by the same letter indicate there are no significant differences within 
samples from those locations. Table 3.1 and table 3.2 further summarizes the mean value 
of different biochemical characteristics of blueberry fruits or leaves of different locations, 
showing the significant difference amongst extracts that were collected from nearby sites 
within St. John’s and surrounding areas. Table 3.1 show leaves from Fort Amherst had 
the highest TPC, Pippy Park leaves had the highest TFC and TTC, and leaves collected 
from Signal Hill had the highest total antioxidant content.  Table 3.2 show fruits from 
Marine Drive had the highest TPC and TTC, Pippy Park fruits had the highest TFC, and 
fruits collected from Fort Amherst had the highest total antioxidant content.   
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Figure 3.1 - Total phenolic content (TPC) of blueberry leaf and fruit extracts. The 
data are expressed as the mean ± SE. GAE: Gallic acid equivilant. All experiments were 
repeated three times.  
 
 
Figure 3.1.1 - Total phenolic content (TPC) of blueberry leaf extracts. The data are 
expressed as the mean ± SE. All experiments were repeated three times. Data are the 
same as that presented in Figure 3.1.  
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Figure 3.1.2 - Total phenolic content (TPC) of blueberry fruit extracts. The data are 
expressed as the mean ± SE. All experiments were repeated three times. Data are the 
same as that presented in Figure 3.1.  
 
  
Figure 3.2 - Total flavonoid content (TFC) of blueberry leaf and fruit extracts. The 
data are expressed as the mean ± SE. All experiments have been repeated three times. CE: 
catechin equivalant.  
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Figure 3.2.1 Total flavonoid content (TFC) of blueberry leaf extracts. The data are 
expressed as the mean ± SE. The experiment has been repeated three times. Data are the 
same as that presented in Figure 3.2.  
 
 
Figure 3.2.2 - Total flavonoid content (TFC) of blueberry fruit extracts. The data are 
expressed as the mean ± SE. The experiment was repeated three times. Data are the same 
as that presented in Figure 3.2.  
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Figure 3.3 - Total tannin content (TTC) of blueberry leaf and fruit extracts. The data 
are expressed as the mean ± SE. The experiment was repeated three times.  
 
 
Figure 3.3.1 - Total tannin content (TTC) of blueberry leaf extracts. The data are 
expressed as the mean ± SE. The experiment was repeated three times. Data is the same 
as that presented in Figure 3.3.  
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Figure 3.3.2 - Total tannin content (TTC) of blueberry fruit extracts. The data are 
expressed as the mean ± SE. The experiment was repeated three times. Data is the same 
as that presented in Figure 3.3.  
 
 
Figure 3.4 - Total antioxidant content of blueberry fruit and leaf extracts. The data 
are expressed as the mean ± SE. The experiment was repeated three times.  
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Figure 3.4.1 - Total antioxidant content of blueberry leaf extracts. The data are 
expressed as the mean ± SE. The experiment was repeated three times. Data are the same 
as that presented in Figure 3.4.  
 
 
Figure 3.4.2 - Total antioxidant content of blueberry fruit extracts. The data are 
expressed as the mean ± SE. The experiment was repeated three times. Data are the same 
as that presented in Figure 3.4.  
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Table 3.1: The mean value of different biochemical characteristics of blueberry 
leaves of different locations 
 
Sample 
Location 
Total Phenolic 
Content 
Total 
Flavonoid 
Content 
Total Tannin 
Content 
Total 
Antioxidant 
Marine Drive 128.47bc ± 0.93 6.09c ± 0.18 20.1b ± 0.41 97.73c ±1.32 
Fort Amherst 144.45d ± 6.27 7.26f ± 0.15 27.78c ± 0.98 93.32b ± 0.41 
Blackhead 111.71a ± 4.59 3.90a ± 0.09 14.3a ±1.12 99.49c ± 0.98 
Pippy Park 184.99e ± 4.31 8.19e ± 0.09 28.9c ± 0.38 111.77d ±1.12 
Signal Hill 132.22c ± 0.50 5.82bc ± 0.14 20.4b ±1.46 120.99e ± 0.38 
Johnson 
Geocentre 
135.23cd ± 2.86 6.66d ± 0.22 20.7b ± 0.85 93.22b ±1.46 
Middle Cove 118.28ab ± 2.29 5.64b ± 0.06 22.69b ± 0.43 64.82a ± 0.85 
Data are expressed as means ± SE; n=3. 
Within the same column, different letters (a,b,c,d,e) indicate statistical 
significance at P < 0.05. Values represented by the same letter indicate there are no 
significant differences within samples from those locations. According to this data, leaves 
from Fort Amherst had the highest TPC, Pippy Park leaves had the highest TFC and TTC, 
and leaves collected from Signal Hill had the highest total antioxidant content.   
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Table 3.2: The mean value of different biochemical characteristics of blueberry 
fruits of different locations 
 
Sample 
Location 
Total Phenolic 
Content 
Total 
Flavonoid 
Content 
Total Tannin 
Content 
Total 
Antioxidant 
Marine Drive 6.60c ± 0.28 0.15b ± 0.01 17.70c ± 0.21 3.19a ± 0.14 
Fort Amherst 4.87ab ± 0.06 0.14b ± 0.001 15.54b ± 0.19 4.50c ± 0.21 
Blackhead 4.72a ± 0.16 0.09a ± 0.003 15.89b ± 0.07 3.65b ± 0.16 
Pippy Park 5.37b ± 0.12 0.17c ± 0.004 13.02a ± 0.45 3.18a ± 0.11 
Data are expressed as means ± SE; n=3. 
Within the same column, different letters indicate statistical significance at 
P<0.05. Fruits from Marine Drive had the highest TPC and TTC, Pippy Park fruits had 
the highest TFC, and fruits collected from Fort Amherst had the highest total antioxidant 
content.   
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3.2 Identifying and quantifying levels of anthocyanin in extracts using HPLC and 
MS analysis 
In order to identify which anthocyanins were present in the extracts, we conducted 
mass spectrometry on the leaves and fruit samples from locations that tested for the 
highest phenolic content as determined by the biochemical analysis. Since biochemical 
assays determined that blueberry samples collected from Pippy Park and Fort Amherst 
had the highest overall phenolic content, we chose to identify major anthocyanin content 
of samples from those two locations. In order to identify the major anthocyanins, we 
matched the m/z with the literature values obtained from Cho et al. (2004) and Esposito et 
al. (2014), which are summarized throughout table 4.1 to table 4.4. Also, figure 4 shows a 
representative image of an HPLC-MS chromatogram which allowed us to detect the 
peaks and retention time, significant to identify anthocyanin components. It was found 
that fruits (Table 4.1 and 4.2) had more detectable anthocyanin compounds than leaves 
(Table 4.3 and 4.4).  
 
Figure 4. Representative image of HPLC chromatogram. Each retention time 
correlates with the peak used to identify the anthocyanin compound. 
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Table 4.1 Major compounds identified in blueberry fruit extracts from Pippy Park 
using mass spectrometry at positive electrospray ionisation (ESI) 
 
Peak 
number 
HPLC 
retention time 
(minutes) 
Compound Identified 
m/z 
value in 
literature 
m/z value 
1 20.2 Delphinidin-3-galactoside 465 464.9 
2 21.7 Delphindin 3-glucoside 465 464.8 
3 22.4 Cyanidin-3-galactoside 449 448.8 
4 23.2 Delphinidin-3-arabinoside 435 434.8 
5 24.2 Cyanidin-3-glucoside 449 448.8 
6 26.6 Petunidin-3-galactoside 479 479.1 
7 28.8 Peonidin 3-galactoside 463 462.9 
8 29.2 Malvidin-3-galactoside 493 492.8 
9 31.9 Peonidin-3-glucoside 463 462.9 
*literature value obtained from Cho et al. (2004) and Esposito et al. (2014) 
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Table 4.2 Major compounds identified in blueberry fruit extracts from Fort 
Amherst using mass spectrometry at positive ESI 
 
Peak 
number 
HPLC 
retention time 
(minutes) 
Compound Identified 
m/z 
value in 
literature 
m/z value 
1 18.4 Delphinidin 3-galactoside 465 465.0 
2 19.9 Delphinidin 3-glucoside 465 465.0 
3 20.7 Cyanidin 3-galactoside 449 449.1 
4 21.6 Delphinidin-3-arabinoside 435 435.0 
5 23.7 Cyanidin 3-glucoside 449 449.1 
6 24.9 Petunidin-3-galactoside 479 479.1 
7 25.6 Peonidin-3-galactoside 463 463.1 
8 26.4 Petunidin-3-arabinoside 449 449.0 
9 28.7 Malvidin-3-galactoside 493 493.1 
10 30.2 Peonidin-3-glucoside 463 463.1 
*literature value obtained from Cho et al. (2004) and Esposito et al. (2014) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
 
Table 4.3 Major compounds identified in blueberry leaf extracts from Pippy Park 
using mass spectrometry at positive ESI 
 
Peak 
number 
HPLC retention 
time (minutes) 
Compound Identified 
m/z value in 
literature 
m/z value 
 
1 22.2 Cyanidin-3-galactoside 449 447.9 
2 26.3 Cyanidin-3-glucoside 449 446.8 
3 34.7 Petunidin 3-galactoside 479 477.4 
4 35.6 Peonidin 3-galactoside 463 463 
5 38.5 Peonidin 3-arabinoside 433 433.4 
6 39.9 Malvidin 3-arabinoside 463 461.6 
*literature value obtained from Cho et al. (2004) and Esposito et al. (2014) 
 
 
Table 4.4 Major compounds identified in blueberry leaf extracts from Fort Amherst 
using mass spectrometry at positive ESI 
 
Peak 
number 
HPLC 
retention time 
(minutes) 
Compound Identified 
m/z value in 
literature* 
m/z value 
1 19.6 Cyanidin-3-galactoside 449 449.0 
2 20.9 Cyanidin-3-glucoside 449 447.0 
3 28.8 Petunidin 3-galactoside 479 479.0 
4 34.5 Peonidin 3-galactoside 463 463.0 
5 36.1 Peonidin 3-arabinoside 433 433.0 
6 38.1 Malvidin 3-arabinoside 463 463.0 
*literature value obtained from Cho et al. (2004) and Esposito et al. (2014) 
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Quantitative analysis using HPLC 
 
We chose two specific standards based on past experiments conducted in our lab, 
delphinidin 3-glucoside and cyanidin 3-galactoside. The two HPLC readings allowed us 
to quantify these specific anthocyanin compounds based on the standards. Using MS, we 
were able to determine that in extracts collected from both locations, the leaves had a 
higher amount of the anthocyanin; cyanidin-3-galactoside (Table 4.6) in comparison to 
the fruits (Table 4.5). Although fruit extracts contained more compounds of anthocyanins 
that were detected at these specific wavelengths (See Tables 4.1 through 4.4), when 
quantifying them, the leaves contained higher levels of the compounds (Table 4.6) 
compared to the fruits (Table 4.5). The retention times differed slightly in order to 
identify the same compound, based on the instrument and its parameters. As long as the 
chronological order of the compounds detected matches the literature values, these 
compounds can be identified.  Also, we were able to determine that there was no 
detectable amount of delphinidin-3- glucoside present in the leaves (Table 4.6), although 
in the fruits, this anthocyanin was present at a greater amount from fruits from Pippy Park 
in comparison to fruits from Fort Amherst (Table 4.5).  
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Table 4.5 Anthocyanin levels detected in blueberry fruit extracts using mass 
spectrometry at positive ESI 
 
Location 
HPLC 
retention 
time 
(minutes) 
Compound Identified 
Concentration 
in Injected 
Sample μg/ml 
(determined 
by standard at 
520 nm) 
Amount of 
anthocyanin per 
gram berry fruit 
weight (mg/100g) 
Pippy 
Park 
21.7 
 
Delphinidin 3-glucoside 248.3 99.3 
Pippy 
Park 
22.4 
 
Cyanidin 3-galactoside 69.0 27.6 
Fort 
Amherst 
19.9 Delphinidin 3-glucoside 
 
133.1 
 
53.2 
Fort 
Amherst 
20.7 Cyanidin 3-galactoside 
 
65.4 
 
26.1 
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Table 4.6 Anthocyanin levels detected in blueberry leaf extracts using MS at positive 
ESI 
 
Location 
HPLC 
retention 
time 
(minutes) 
Compound 
Identified 
Concentration in 
Injected Sample 
μg/ml (determined 
by standard at 520 
nm) 
Amount of 
anthocyanin per 
gram berry leaf 
weight (mg/100g) 
Pippy 
Park 
22.2 
Cyanidin-3-
galactoside 
288.0 115.2 
Fort 
Amherst 
19.6 
Cyanidin-3-
galactoside 
442.6 177.0 
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3.3 Pilot bioavailability diet study 
Although the amount of polyphenols in blueberry extracts could be determined 
using biochemical experiments, it was important to start exploring the bioavailability of 
these extracts in the body. Therefore, we conducted a dietary pilot study to detect how 
much extract was absorbed in different organs, with specific focus on the brain, using a 
mouse model. A two-week trial diet study was conducted to observe how much leaf and 
fruit of lowbush blueberries collected from Pippy Park would be absorbed in different 
organs of C57bl/6 mice. This strain of mice was used for our experiment as our lab aims 
to use a Parkinson’s disease model of the same strain for research in the future. Samples 
were chosen from Pippy Park because according to the results from biochemical assays, 
these extracts had one of the overall higher levels of phenolic content. Mice were housed 
three in each cage, separated according to control, 0.2% leaf consumption and 2% fruit 
consumption via oral gavage. All mice were given the standard amount of food and water. 
Four mice died during this study due to perforation in the esophagus and aspiration due to 
extracts being administered accidentally via the trachea and entering the lungs. This was 
due to two main factors. The first was improper techniques of conducting oral gavage on 
my part, the second factor was due to the fact that the syringe given by the animal care 
staff was an inaccurate size for the animal weight, which caused perforation in the mouse 
lungs when administered by an animal care technician. Two mice from the control group 
and two mice from the leaf extract group died during this portion of the study. Excluding 
the four mice that died during this trial study, results showed that there was no significant 
weight gain or loss in the control (Figure 5.1), fruit (Figure 5.3) or leaf (Figure 5.2) 
group. A comparison of all three groups showed no significant weight change from the 
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initial to the final date of the trial study (Figure 5). Food and water intake varied each 
day, and there was no obvious pattern unless a mouse in that cage expired, which resulted 
in lower levels of overall food (Figure 5.4) and water intake (Figure 5.5). In order to 
analyze if the blueberry fruit or leaf extract was absorbed by different organs in the body, 
the mouse tissues were further tested using HPLC-MS to detect, identify and quantify 
specific anthocyanin compounds from blueberries in the biological tissues. Unfortunately, 
results indicated that there were no detectable anthocyanin compounds found in the 
mouse organs using HPLC-MS, therefore there is no data to be shown for that portion of 
the experiment.  
 
 
Figure 5 - Average weight change of C57bl/6 mice. Mice of control group and leaf 
group (C3, L3 and L6) expired July 23rd, mouse of control group (C1) expired July 24th, 
2015. Although there is a variation in the weight of mice from different groups, it is not a 
significant difference. Overall, the weight did not fluctuate more than one gram for any 
group from initial to final day of study. Data is expressed as mean ±SE.  
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Figure 5.1 - Weight change of C57bl/6 mice of the control group. C3 expired July 23rd, 
C1 expired July 24th, 2015. C represents the control group that were not administered 
blueberry fruit or leaf extract. Weight did not vary drastically for mice over the trial study 
of two weeks.  
 
Figure 5.2 - Weight change of C57bl/6 mice consuming 0.2% blueberry leaf extract. 
L4 and L6 expired July 24th, 2015. L represents the mice administered 0.2% leaf extract 
via oral gavage. Weight did not vary drastically for mice over the trial study of two 
weeks. 
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Figure 5.3 - Weight change of C57bl/6 mice administered 2% blueberry fruit 
extract. F represents mice administered 2% fruit extract via oral gavage. Weight did not 
vary drastically for mice over the trial study of two weeks. 
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Figure 5.4 - Average food consumption of C57bl/6 mice administered 2% blueberry 
fruit extract (fruit), 0.2% leaf extract (leaf), or no extract (control). Average food 
consumption decreased for all three groups of mice by the end of the study, with mice 
consuming leaf extract having the greatest decline in food intake. These values take into 
consideration that two mice in the control group and two mice in the leaf group expired 
early in the trial study.  
 
 
 
0
1
2
3
4
5
1 2 3 4 5 6 7 8 9 10 11 12 13
A
m
o
u
n
t 
o
f 
fo
o
d
 c
o
n
su
m
ed
 p
er
 d
ay
 
(g
)
Day  
Control Fruit Leaf
63 
 
 
Figure 5.5 - Average water consumption of C57bl/6 mice administered 2% 
blueberry fruit extract (fruit), 0.2% leaf extract (leaf), or no extract (control). 
Average water consumption for all control and leaf groups of mice decreased by the end 
of the study, with mice consuming fruit extract having no significant change in water 
intake. These values take into consideration that two mice in the control group and two 
mice in the leaf group expired early in the trial study.  
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3.4 Cell culture 
After determining the rich phenolic content in blueberries using biochemical 
assays and HPLC-MS, we wanted to test the neuro-protective capabilities these extracts 
had on the brain, specifically microglial cells. We chose to use fruit and leaf extracts from 
Pippy Park, which showed to have one of the highest overall phenolic levels. We 
quantified the cells that could offer potential neuroprotection by counting the cells stained 
with DAPI in all treatments. All cell counts were performed with two individuals to 
ensure accuracy.  Light microscopy images (Figure 6) and confocal images (Figure 6.1) 
captured microglia morphology in control conditions with elongated shape, and activated 
condition, treated with α-synuclein to have a ‘fried egg’ shape. Dark punctae was also 
visible in cells treated with glutamate for 24 hours. Mixed morphology is also apparent in 
confocal images of cells treated with blueberry extract (Figure 6.1). Figure 6.2 showed 10 
µM and 100 µM glutamate treatment decreased the average % of control cells. We also 
used the solvent in which extracts were prepared as a treatment condition to ensure that 
the solvent used for the berry extracts was not harming the cells (Figure 6.2). Results 
showed no statistically significant difference between control and solvent treatments. 
Blueberry fruit and leaf extracts from Pippy Park were then tested further and results from 
Figure 6.3 showed that glutamate and α-synuclein caused a significant percentage of cell 
damage evident by the decrease in DAPI-stained nuclei. Since there was also a significant 
decrease in % of control cells when blueberry fruit extract added to cells treated with 
glutamate, no significant neuroprotective effects was determined. There was an increase 
in average % of control cells with blueberry leaf extract added to cells treated with 
glutamate indicating a neuroprotective effect. The average % of control cells present also 
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increased once the blueberry fruit and leaf extracts were added to conditions treated with 
α-synuclein, indicating a neuroprotective role of blueberries (Figure 7.3). 
 
           
Figure 6. Light microscope cell culture representative images.  Microglial cell images 
captured at 80X magnification using light microscopy after 24 hours of treatments of 
various conditions. Cell morphology captured using high magnification differential 
interference contrast (H/DIC). Healthy cells in control conditions are observed to be more 
elongated and activated cells treated with α-synuclein are observed to be a flatter, 
irregular shape. Cells treated with glutamate are observed to have dark punctae present 
indicating cell disruption and irregular circular shape morphology.  (Ctrl=Control, 
Glut=100 µM glutamate, α-syn=100 ng/ml α-synuclein).  
 
Ctrl α-syn Glut 
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Figure 6.1 Confocal cell culture representative images. Microglial cell images 
captured by Dr. Noriko Daneshtalab using confocal microscopy. Cells have been treated 
for 24 hours with 100 ng/ml α-synuclein or 100 µM glutamate, or either condition plus 
12.5 µg/ml blueberry fruit extract or 1.25 µg/ml leaf extract. Microglia are labelled with 
antibodies Iba1 and Alexa 488. Cells treated with α-synuclein or glutamate are in an 
activated state (‘fried egg’ shape) and both activated and healthy states (more elongated) 
are observed when treated with blueberry extracts based on morphology. (Glut=100 µM 
glutamate, α-syn=100 ng/ml α-synuclein).   
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Figure 6.2 - Average percentage of living microglial cells undergoing different 
treatments. Cell count was calculated as a percentage of the control cells. The % of 
control cells was determined by quantifying the amount of DAPI-stained nuclei. (α-
synuclein concentration = 100 ng/ml). Statistical significant difference (*) was 
determined between control and treatment wells by One-way ANOVA, followed by 
Tukey’s test (P< 0.05). Data are expressed as means ± SE). n=3-4 (n indicates the number 
of wells on day of experiment). Primary microglial cells were plated at a seeding density 
of ≥30,000 cells/cm2 per well.  
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Figure 6.3 – The neuroprotective role of blueberry extracts on microglial cells 
undergoing activation. Primary microglial cells were plated at a seeding density of 
≥40,000 cells/cm2 per well. The % of control cells was determined by quantifying the 
amount of DAPI-stained nuclei. Statistical significant difference (p<0.05) was determined 
between control and treatment wells (*), between 100 µM glutamate and 100 µM 
glutamate plus 12.5 µg/ml fruit extract or 1.25 µg/ml leaf extract (**), and between 100 
ng/ml α-synuclein and 100 ng/ml α-synuclein plus 12.5 µg/ml fruit extract or 1.25 µg/ml 
leaf extract wells (***). All data was calculated by One-way ANOVA, followed by 
Tukey’s test (p< 0.05). Data are expressed as average % of the control ± standard error 
(SE). n=5-11 (n indicates the number of wells on day of experiment). Experiments were 
repeated three times.  
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Chapter 4: Discussion 
Blueberry fruits and leaves from seven different locations grown in the St. John’s 
area of NL were collected.  Extracts from these samples were analyzed using the 
biochemical assays for this research project. It was found that blueberry fruit and leaf 
extracts were high in phenolic compounds, such as tannins, anthocyanins, flavonoids and 
total antioxidant capacity. In all of the biochemical assay experiments with the exception 
of tannins, leaves had a significantly higher content of total phenolic and flavonoid 
content. The blueberry leaves also had a higher level of total antioxidant capacity, 
measured as the total radical scavenging capacity, which indicates that their ability to 
scavenge free radicals is higher in comparison to the berry fruits, which is consistent with 
previous findings (Vyas et al., 2013). In order to get more specific results, the mean value 
of different biochemical analyses of blueberry fruits and leaves from different locations 
was calculated, and determined which locations were statistically similar and different 
from one another, where within the same column, different letters indicate statistical 
significance at P < 0.05 (Table 3.1 and 3.2). According to the statistical analysis of the 
data obtained for blueberry fruits, the TPC was the highest in samples from Marine Drive, 
the TFC was highest for Pippy Park, the TTC was the greatest in samples from Marine 
Drive and the total antioxidant content was the highest in samples from Fort Amherst. For 
the blueberry leaves, samples from Pippy Park had the highest TPC, TFC and TTC. 
Leaves collected from Signal Hill had the highest antioxidant capacity. When analyzing 
the biochemical assays from different locations, there are significant differences between 
samples from some locations, while there is no significant difference found between other 
locations. This could be due to factors such as agronomic conditions, light, temperature, 
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and even genotype could influence some antioxidant components (Hosseinian et al., 
2007) and these factors could differ based on locations these samples were collected 
from. This is also supported by previous literature where blueberry of the same cultivars 
grown in different locations and different blueberry cultivars grown in the same location 
had significantly different antioxidant activity, suggesting the influence of genotype and 
environmental factors (Connors et al., 2002). It is also evident to see that in most cases, 
the blueberry leaves have overall higher TPC, TFC, TTC and total antioxidant capacity 
compared to their respective fruits, which is also supported in previous findings (Vyas et 
al., 2013).  
Since we determined that there are high levels of overall antioxidants within the 
leaves and fruits of blueberries, next we wanted to determine the bioavailability of these 
compounds in the body by conducting a rodent diet study. In a two-week pilot study, 
C57bl/6 mice were monitored and administered water for the control group, 0.02% leaf 
extract, or 2% fruit extract via oral gavage. The extracts were chosen from the Pippy Park 
location, which showed one of the highest overall levels of polyphenols in the 
biochemical assays. During the study, two mice in the control group and two mice in the 
leaf group died early due to either perforation of syringe in the esophagus or when 
aspiration occurred (the syringe was placed in the trachea and filled lungs with fluid). 
Results showed that there was no significant weight gain or loss among any of the groups, 
which matches with previous findings in mice that were fed a blueberry supplemented 
diet (Adams et al., 2011) and rats administered a 2% blueberry fruit diet (Randeiro et al., 
2012), although there was a decrease in food and water consumption in mice of the leaf 
group. This could be due to the loss of appetite after being administered leaf extract, 
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which may not appeal to their taste buds while the fruit extract may be more appealing 
since other studies have added blueberry fruit extract to feed that has been successfully 
consumed by the mice (Andres-Lacueva et al., 2005; Aiyer et al., 2011a). The lack of 
significant change in weight could also be due to the fact that although administered 
different extracts, the amount of food and water administered was consistent throughout 
the entire study and there were no noticeable changes in intake overall. A longer trial 
study will have to be conducted in the future in order to observe if the extract influenced 
water or food intake, or cause any significant changes in the weight of these mice. We 
used the same concentration of 2% blueberry fruit extract as stated in other research 
investigating fresh blueberry fruits (Willis et al., 2010), although their experiments 
included rats of different age groups and longer trials which focused on quantifying other 
factors such as microglial activation in the hippocampus. Previous literature showed that 
the anthocyanin content in blueberries was 7.2 ± 0.5 mg/g dry matter (Lohachompol et 
al., 2004), so we can estimate a 2% diet blueberry fruit diet for mice would contain ~0.72 
mg of anthocyanin since we used 0.1 g of blueberry fruit per dose. Since there is limited 
data on leaf extracts in diet studies, future research is necessary to determine the 
concentration of anthocyanin present in blueberry leaves.      
According to Aiyer et al. (2011a), blueberry fruits contain a moderate amount of 
anthocyanin (~ 4000 parts per million), and we analyzed them further in our berry 
samples. In order to quantify the amount of anthocyanins and identify the types of 
anthocyanins absorbed by different organs in mice and the amount detected in our 
extracts, we ran all samples using HPLC-MS. We chose fruits and leaves from Fort 
Amherst and Pippy Park, which had the highest levels of antioxidants as determined by 
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the biochemical assays. We ran HPLC-MS on extracts from these two locations, and 
identified the anthocyanins according to previous methods similar to Cho et al. (2004) 
and Esposito et al. (2014). We identified the following 10 different anthocyanin 
compounds in blueberry fruits (Table 4.1 and Table 4.2) from the two locations using 
different solvents; Delphinidin 3-galactoside, Delphinidin 3-glucoside, Cyanidin 3-
galactoside, Delphinidin-3-arabinoside, Cyanidin 3-glucoside, Petunidin-3-galactoside, 
Peonidin-3-galactoside, Petunidin-3-arabinoside, Malvidin-3-galactoside and Peonidin-3-
glucoside. In previous studies analyzing anthocyanins in lowbush blueberry fruits using 
HPLC-MS, many of these anthocyanins were also detected (Barnes et al., 2009). In 
comparison, we detected and identified six different anthocyanin compounds in the 
blueberry leaves (Table 4.3 and Table 4.4); Cyanidin-3-galactoside, Cyanidin-3-
glucoside, Petunidin 3-galactoside, Peonidin 3-galactoside, Peonidin 3-arabinoside, 
Malvidin 3-arabinoside. This analysis on leaves is still relatively new research, as other 
literature suggests that more studies on anthocyanins are necessary in the vegetative parts 
and leaves of plants (Naczk et al., 2006). The detection of anthocyanins confirmed the 
presence of these bioactive compounds in both the blueberry leaf and fruit extracts. In 
order to quantify these compounds, we used two standards that were used in our lab in 
previous experiments; cyanidin-3-galactoside and delphinidin-3-0-glucoside. With the 
contribution from our summer student Scott Unruh, we were able to identify that out of 
the two anthocyanins, only cyanidin-3-galactoside was detectable in the blueberry leaves. 
When comparing extracts from both locations, we found that the leaves and the fruits 
from Pippy Park had a higher quantity of the anthocyanins cyanidin-3-galactoside and 
delphinidin-3-glucoside (Table 4.5 and Table 4.6). Confirming that anthocyanins were 
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present in the berry and leaf extracts, we then proceeded to test if anthocyanins from 
blueberries were present in organs of mice from the bioavailability diet study. There were 
no detectable traces of anthocyanins present in the organs we analyzed, including the 
brains (cortex and cerebellum), right and left kidneys, heart, and liver. Although there is 
literature to support that anthocyanin bioavailability in organs are detectable in diet 
studies involving rodents (Andres-Lacueva et al., 2005), our research focuses on wild 
blueberry fruit and leaves native to NL, where the entire extract is used for consumption, 
not specific anthocyanins or powdered forms with controlled phenolic components. Past 
studies looked at blackberry diets in rats where they showed that native anthocyanins 
from berries were detected in stomach with no metabolites, indicating that the 
anthocyanins absorbed were intact. Methylated forms of anthocyanins from the diet were 
detected in the brain of rats, indicating that they could permeate the blood brain barrier 
(Talavera et al., 2005). Therefore, we tested brain material to observe detectable 
anthocyanins in blueberry fed mice.     
  Limitations for this portion of the experiment includes several factors. For 
example, the instrumentation used to detect HPLC-MS has never been used on animal 
tissue before, therefore detection of anthocyanins could have interference due to other 
proteins and organic material present in the sample. Using whole blueberries in the feed 
instead of a controlled diet with measured levels of anthocyanins could also play a role in 
undetectable amounts of anthocyanins in tissues. The presence of metabolites in the 
extracts could also play a role in the lack of anthocyanin detection since metabolites 
increase the complexity of studying phytochemicals of berries and affects their 
bioavailability. For example, how polyphenols are metabolized in the body and how the 
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metabolites already present in the gut and liver influence the effectiveness of the 
polyphenols in vivo. Since anthocyanidins conjugate with different sugar moieties to 
produce anthocyanins, this influences how the gut metabolizes and absorbs the compound 
(Wu et al., 2005). The bioavailability of different polyphenols differs as well, and those 
mostly in our diet do not always have the best bioavailability profiles (D’Archivio et al., 
2007).  Also, there could be a loss of organic material during the extraction process since 
mouse organs are of such a small quantity, which could have resulted in loss of detectable 
anthocyanin content.  
In a previous study conducted in our lab by Vyas et al., 2013a, rat brain cell 
cultures consisting of glial cells and neurons were exposed to glutamate toxicity. Their 
results found that leaf extract from both lingonberry and blueberries showed 
neuroprotection, while only blueberry fruits showed neuroprotection against glutamate 
toxicity. Dosages for glutamate exposure and berry extract for cell culture were 
established previously in our lab (Vyas et al., 2013a).  Therefore, we focused solely on 
blueberry extracts to determine their protective role in microglial cells of mice. For the 
first set of experiments with cell culture, plates were coated with PLO as recommended 
by the supplier for greater cell adherence, but results showed that there was not a great 
difference in cell attachment in wells coated or uncoated with PLO, therefore for the 
remaining sets of experiments, the wells were left uncoated. In order to activate the 
microglial cells, glutamate and α-synuclein were used. We chose α-synuclein as past 
experiments have observed that in response to this cytosolic protein, there is an 
inflammatory response indicated by release of pro-inflammatory cytokines in astrocytes 
and neurons (Lee et al., 2010). The dosage for α-synuclein was previously established by 
75 
 
the research team Dr. Weber was a part of in Germany, conducted at the University of 
Marburg (data not published). Light microscopy images (Figure 6) with representative 
images of microglial cells distinctly demonstrated different morphology of healthy and 
activated cells. Microglia in control conditions had an elongated shape while activated 
cells treated with α-synuclein were observed to have a ‘fried egg’ shape. Cells treated 
with glutamate for 24 hours had an increase in dark punctae, indicating disruption of cell 
bodies.  The presence of dark punctae and irregular circular shape morphology was also 
observed previously in our lab where glial and neuronal cells were treated with glutamate 
(Vyas et al., 2013).  Results from Figure 6.2 showed that both 10 µM and 100µM 
glutamate treatment significantly decreased (P<0.05) the average % of control (untreated) 
cells, although 100 µM decreased slightly more cells (although not significantly), 
therefore we narrowed it down to 100 µM glutamate to treat microglia cultures in 
subsequent experiments to stay consistent with previous work conducted in our lab. We 
also used the solvent in which extracts were prepared as an independent treatment 
condition in the beginning to ensure that the solvent used for the berry extracts was not 
harming the cell growth. As there was no statistically significant difference (P<0.05) 
between control and solvent treatments, further experiments no longer tested with 
‘solvent’ treatment independently, since the solvent used to dissolve the berry and leaf 
extract had no negative effect on the cells’ integrity. Blueberry fruit and leaf extracts from 
Pippy Park were then tested further, which, according to results from biochemical assays, 
showed to contain one of the highest constituents of phenolics on activated microglial cell 
cultures. Results from Figure 6.3 showed that glutamate and α-synuclein used for cell 
activation caused a significant percentage of cell damage evident by the decrease in 
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DAPI-stained nuclei, indicating the effect of these pro-inflammatory factors on cell loss. 
There was also a significant decrease in % of control cells when blueberry fruit extract 
was added to cells treated with glutamate, which indicates that blueberry fruit shows no 
significant neuroprotective effects on these cells. This could suggest certain 
concentrations of blueberry fruit extract could be ineffective to microglial cells, as 
previous literature has found certain concentrations of the antioxidant oxyresveratrol 
reduces viable glial cells following mild traumatic injured (Weber et al., 2012). Results 
showed that there was an increase in the number of viable cells once blueberry leaf 
extract was added to cells treated with glutamate indicating a neuroprotective effect. 
There was also a greater average % of control cells present once the blueberry fruit and 
leaf extracts were added to conditions treated with α-synuclein, indicating a 
neuroprotective role blueberries can have on activated microglial cells (Figure 6.3). One 
possibility is that blueberry anthocyanins are able to reduce the amount of inflammatory 
mediators that are released, which in turn reduced damage caused by oxidation as seen by 
Youdim et al. (2002) in an atherosclerosis study. Many neurological disorders such as PD 
and AD are associated with oxidative stress, which could lead to severe cellular damage, 
necrosis and apoptosis (Routray & Orsat, 2011), and more emerging evidence supports 
the idea that microglia could potentially be a source of ROS which causes neuronal 
damage leading to neurodegenerative diseases (Block et al., 2007b). Therefore, the 
important antioxidant properties in blueberries may be highly beneficial for the brain. As 
results show, by being able to inhibit cell death with blueberry extracts that have been 
damaged by α-synuclein, there is potential to slow down the progress of neurological 
diseases associated with α-synuclein localization. Previous literature found that 
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blueberries decreased activation of microglial cells in intraocular hippocampal grafts 
(Willis et al., 2011) but also increased newly generated cells in the hippocampus of rats 
after supplementation with blueberries (Casadesus et al., 2004), which agrees with our 
data after fruit and leaf extracts were added to cells treated with α-synuclein. This 
regeneration of cells could also potentially slow down neurogenesis progression.  
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Chapter 5: Conclusions and future directions 
This study analyzed the nutraceutical properties of blueberries native to 
Newfoundland and Labrador. Biochemical assays were able to compare the different 
phenolic contents between blueberry fruits and leaves. Results showed higher phenolic, 
flavonoid, tannin and total antioxidant content in leaves when compared to fruits. We 
were also able to determine that although samples were collected from nearby locations 
within St. John’s and the surrounding area, the phenolic content varied significantly 
between the fruits and the leaves collected from different locations. The HPLC-MS 
results showed anthocyanins in the fruits and leaves, indicating that leaves had a higher 
quantity of specific anthocyanins while fruits had a greater number of detectable 
anthocyanin compounds.  The cell culture study indicated that fruits and leaves have an 
overall positive effect on reducing inflammation of activated microglial cells in the brain, 
which is significant for future neurological studies.  
One of the limitations of this research is that the extraction procedure for the diet 
study differed greatly from the other experiments, which also used different solvents. This 
is an inconsistency in our experiment, but difficult to control until further experiments 
find common solvents for extractions that are safe and effective in multiple experimental 
approaches. Additionally, although these initial results are significant to research in the 
neuroprotective properties of blueberries, future studies will be needed to establish 
toxicity levels, particularly for blueberry leaves. Due to limited previous investigations on 
blueberry leaves, more research is needed before establishing dosage and efficacy of 
these extracts.  
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The dietary recommendations of the Canadian Food Guide were set to focus on 
health management and disease prevention. The reference values coded for these 
recommendations were considered sufficient to meet the needs of a majority of the 
Canadian population. Now, with emerging evidence on genetic predispositions and 
mutations, environmental factors, and diverse backgrounds in terms of race and culture, 
these guidelines are too general for the growing population. With allometric conversions 
from different rodent studies to humans, research has shown that even one to two cups of 
blueberries a day could have health benefits (Adams et al., 2011). With the increase in 
detection of neurodegenerative diseases, it is necessary to turn focus towards 
nutraceutical products that could be synthesized as supplements or added to traditional 
meals in order to effectively target prevention and reduced incidences of neurological 
problems.  Treatments that are phytochemical-based could be taken into clinical trials in 
the future for neurological conditions, due to the fact that phytochemicals have low 
toxicity levels and their bioavailability is high (Mecocci et al., 2014). Future directions 
involving human trials would present stronger evidence relating the role of nutrients to 
cognitive function.  This could also help to determine if short term or long term use of 
nutraceuticals would be effective in reducing the progression and incidence of 
neurodegenerative diseases.  
It is important not to group the functions of antioxidants, but to analyze the role 
individual components of antioxidants play in protecting and regenerating brain cells. By 
identifying these key roles of different antioxidant components, it will be easier to isolate 
the function and mechanism of action required to protect the brain. Future studies are 
needed to analyze the role of different isolated antioxidants present in blueberry fruits and 
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leaves, as well as how they are metabolized and absorbed in the body, to better 
understand their roles in neuroprotection. It is important to recognize and understand how 
these natural sources of antioxidants could further slow the progress or prevent certain 
neurodegenerative diseases.  
In essence, blueberry fruits and leaves, in a variety of forms from powders to tea 
leaves, have great potential and could have a huge impact on future treatments regarding 
neurodegenerative health issues. 
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